Synthesis and Evaluation of 5-Halo 2′,3′-Didehydro-2′,3′-Dideoxynucleosides and their Blocked Phosphoramidates as Potential Anti-Human Immunodeficiency virus Agents: An Example of ‘Kinase Bypass’
Free accessResearch articleFirst published online December, 1997
Synthesis and Evaluation of 5-Halo 2′,3′-Didehydro-2′,3′-Dideoxynucleosides and their Blocked Phosphoramidates as Potential Anti-Human Immunodeficiency virus Agents: An Example of ‘Kinase Bypass’
A series of 5-halo derivatives of the anti-human immunodeficiency virus (HIV) nucleoside analogue d4T have been prepared by a general and highly stereoselective route. A key step is the electrophilic addition of N-iodosuccinimide to furanoid glycols. The 2′-iodo nucleosides thus obtained produced the corresponding 2′/3′-didehydro-2′/3′-dideoxynucleoside in a two-step elimination reaction upon treatment with potassium t-butoxide followed by sodium methoxide. The derivatives were tested for their ability to inhibit the replication of HIV-1 and HIV-2 in cell culture. Replacement of the thymine 5-methyl group of the parent nucleoside analogue (d4T) by I, CI or F resulted in compounds that showed poor antiviral activity. In view of this, we studied the application of blocked phosphate (phosphoramidate) technology to probe the efficacy of intracellular monophosphate delivery in these systems. In one case, significant antiviral potency was obtained in this way.
Abdel-MegiedA.E.-S, HansenP., PedersenE.B., & NielsenC.M. (1991) New synthesis of 2′,3′-didehydro-2′,3′-dideoxynucleosides. Acta Chemica Scandinavica45: 1060-1063.
2.
BabaM., PauwelsR., HerdewijnP., De ClercqE., DesmyterJ., & VandeputteM. (1987) Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative are potent inhibitors of human immunodeficiency virus in vitro. Biochemical and Biophysical Research Communications142: 128-134.
3.
BalzariniJ., KangG-J, DalaiM., HerdewijnP., De ClercqE., BroderS., & JohnsD.G. (1987) The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2′,3′-didehydro-2′,3′-dideoxyribonucleosides: a comparison with their parental 2′,3′-dideoxyribonucleosides. Molecular Pharmacology32: 162-167.
4.
BalzariniJ., HolyA., JindrichJ., NaesensL., SnoeckR., ScholsD., & De ClercqE. (1993) Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2, 6-diaminopurine. Antimicrobial Agents and Chemotherapy37: 332-338.
5.
BalzariniJ., KarlssonA., AquardoS., PernoC-F, CahardD., NaesensL., De ClercqE., & McGuiganC.Mechanism fo anti-HIV action of masked alaninyl d4T-MP derivatives (1996) Proceedings of the National Academy of Sciences, USA93: 7295-7299.
6.
CoeP.L., TalekarR.R., & WalkerR.T. (1994) The synthesis of difluoro and trifluoro analogues of pyrimidine deoxyribonucleosides: a novel approach using elemental fluorine. Journal of Fluorine Chemistry69: 19-24.
7.
DanenbergP.V. (1977) Thymidylate synthetase - α target enzyme in cancer chemotherapy. Biochimica et Biophysica Acta473: 73-92.
8.
JoshiB.V., RaoS., & ReeseC.B. (1992) Conversion of some pyrimidine 2′-deoxyribonucleosides into the corresponding 2′,3′-didehydro-2′,3′-dideoxynucleosidcs. Journal of the Chemical Society PerkinTransactionsI: 2537-2544.
9.
JungM.E., & GardinerJ.M. (1992) Synthesis of antiviral nucleosides from crotonaldehyde. Tetrahedron Letters33: 3841-3844.
KhwajaT.A., & HeidelbergerC. (1967) Fluorinated pyrimidines XXIX. Synthesis of 2′,3′-dehydro-5-fluoro-2′-deoxyuridine and 2′,3′-dideoxy-5-fluorouridine. Journal of Medicinal Chemistry10: 1066-1070.
12.
KimC.U., & MiscoP.F. (1992) Facile, highly stereoselective synthesis of 2′,3′-dideoxy and 2′,3′-didehydro-2′,3′-dideoxynucleosides via a furanoid glycal intermediate. Tetrahedron Letters33: 5733-5736.
13.
LarsenE., KofoedT., & PredersenE.B. (1995) Synthesis of 2′,3′-anhydro-2′-deoxyuridines and 2′,3′-didehydro-2′,3′-dideoxyuridines using polymer supported fluoride. Synthesis:1121-1125.
14.
McDonaldF.E., & GleasonM.M. (1995) Asymmetric synthesis of stavudine (d4T) and cordycepin by cycloisomerization of alkynyl alcohols to endocyclic enol ethers. Angewandte Chemie International Edition in English34: 350-352.
15.
McGuiganC., PathiranaR.N., BalzariniJ., & De ClercqE. (1993a) Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT. Journal of Medicinal Chemistry36: 1048-1052.
16.
McGuiganC., KinchingtonD., NichollsS.R., NicksonC., & O'ConnorT.J. (1993b) Kinase bypass: a new strategy for anti-HIV drug design. Bioorganic and Medicinal Chemistry Letters3: 1207-1210.
17.
McGuiganC., CahardD., SheekaH.M., BalzariniJ., & De ClercqE. (1996a) Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. Journal of Medicinal Chemistry39: 1748-1753.
18.
McGuiganC., SalgadoA., YarnoldC., HarriesT.Y., & De ClercqE. (1996b) Novel nucleoside phosphoramidates as inhibitors of HIV: studies on the stereochemical requirements of the phosphoramidate amino acid. Antiviral Chemistry and Chemotherapy7: 184-188.
19.
McGuiganC., CahardD., SalgadoA., De ClercqE., & BalzariniJ. (1996c) Phosphoramidates as potent pro-drugs of anti-HIV nucleotides: Studies in the amino region. Antiviral Chemistry and Chemotherapy7: 31-36.
20.
McGuiganC., TsangH-W, CahardD., TurnerK., VelazquezS., SalgadoA., BidoisL., NaesensL., De ClercqE., & BalzariniJ. (1997a) Phosphoramidate derivatives of d4T as inhibitors of HIV: the effect of amino acid variation. Antiviral Research35: 195-204.
21.
McGuiganC., CamarasaM-J, EgberinkH., HartmannK., KarlssonA., PernoC-F, & BalzariniJ. (1997b) Design, synthesis and biological evaluation of novel nucleotide prodrugs as inhibitors of HIV replication. International Antiviral News5: 19-21.
22.
MansuriM.M., StarrettJ.E., WosJ.A., TortolaniD.R., BrodfuehrerP.R., HowellH.G., & MartinJ.C. (1989) Preparation of 1-(2,3-dideoxy-β-D-glycero-pent-2-enofuranosyl)thymine (d4T) and 2′,3′-dideoxyadenosine (ddA): general methods for the synthesis of 2′,3′-olefinic and 2′,3′-dideoxynuclesides analogues active against HIV. Journal of Organic Chemistry54: 4780-4785.
23.
PrusoffW.H. (1959) Synthesis and biological activity of iododeoxyuridine, an analog of thymidine. Biochimica et Biophysica Acta32: 295-196.
24.
RobinsM.J., WilsonJ.S., MadejD., LowN.H., HansskeF., & WnukS.F. (1995) Nucleic acid related compounds. 88. Efficient conversions of ribonucleosides into their 2′,3′-anhydro, 2′(and 3′)-deoxy, 2′,3′-didehydro-2′,3′-dideoxy, and 2′,3′-dideoxynucleoside analogues. Journal of Organic Chemistry60: 7902-7908.
25.
TakleA., & KocienskiP. (1995) A new approach to 1,7-dioxaspiro(5.5)undec-4-enes via metallated allenol ethers. Synthesis of lacrimin A. Tetrahedron46: 4503-4516.
26.
TaniguchiM., KogaK., & LamadeS. (1974) Stereochemical studies XXX. Stereoselective synthesis of D-ribose from L-glutamic acid. Tetrahedron30: 3547-3552.
27.
Van AerschotA., HerdewijnP., BalzariniJ., PauwelsR., & De ClercqE. (1989) 3′-Fluoro-2′,3′-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent amongst a series of new 2′- and 3′-fluorinated 2′,3′-dideoxynucleoside analogues. Journal of Medicinal Chemistry32: 1743-1748.
28.
Van AerschotA., EveraertD., BalzariniJ., AugustynsK., JieL., JanssenG., PeetersO., BlatonH., De RanterC., De ClercqE., & HerdewijnP. (1995) Synthesis and anti-HIV evaluation of 2′,3′-dideoxyribo-5-chloropyrimidine analogues: reduced toxicity of 5-chlorinated 2′,3′-dideoxynucleosides. Journal of Medicinal Chemistry33: 1833-1839.
